BEHAVIORAL PHYSIOLOGY OF BODY WEIGHT REGULATION

体重调节的行为生理学

基本信息

  • 批准号:
    7878213
  • 负责人:
  • 金额:
    $ 9.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-15 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The current 'epidemic' of obesity in the United States has been ascribed to environmental changes that have occurred over the past two decades. Prominent in this is the ready economic availability of highly palatable, high caloric density foods. Although numerous studies have focused on hormones such as insulin and leptin, and neurotransmitters, which act at the medial hypothalamus to regulate calorie intake, little attention has focused on the potential regulation of central nervous system (CNS) circuitry which mediates the rewarding or motivating aspects of food. This circuitry includes the midbrain dopamine neurons (DA) as well as other forebrain areas with which the medial hypothalamus has extensive direct and indirect connections. Our lab has evidence that the candidate adiposity signals insulin and leptin decrease performance in behavioral tasks that assess food reward and that require DA signaling. We hypothesize that the midbrain DA neurons whose cell bodies are in the ventral tegmental area (VTA) serve as a direct target for insulin and leptin. In this proposal we will test this hypothesis in rats by studying the effects of insulin or leptin infused directly into the VTA on behavioral procedures that evaluate different aspects of food reward/motivation: a free-feeding ingestive task, the conditioned place preference, and self-administration. We will compare sweet vs. fat food reward in these tasks, to evaluate macronutrient specificity. We will infuse insulin receptor antisense oligonucleotides directly into the VTA to determine the role of endogenous insulin signaling in modulation of food reward behavior. Because VTA DA neurons express insulin and leptin receptors, we will measure insulin- and leptin-stimulation of the PI3 kinase pathway as an index of direct VTA activation at the cellular level. Comparable studies will be carried out in rats fed a defined high fat diet snack in addition to chow, a model of CNS insulin resistance that we have recently developed. We will use this model to test whether the behavioral and cellular actions of insulin and/or leptin at the VTA are blunted by high fat diet ingestion, i.e., a model of VTA insulin or leptin resistance. Together these studies will evaluate the potential regulation of reward circuitry and function in the CNS by adiposity signals. Findings from these studies will contribute to the long-term goal of learning whether altered food reward value contributes to the (relative) overeating which occurs in association with the availability of highly palatable foods, independent of caloric need.
描述(由申请人提供):美国目前的肥胖“流行病”归因于过去二十年发生的环境变化。这方面的突出特点是,高可口、高热量密度的食物可以随时经济地获得。虽然许多研究都集中在激素,如胰岛素和瘦素,和神经递质,在内侧下丘脑,以调节热量的摄入,很少注意集中在中枢神经系统(CNS)电路的潜在调节,介导的奖励或激励方面的食物。这个回路包括中脑多巴胺神经元(DA)以及与内侧下丘脑有广泛直接和间接联系的其他前脑区域。我们的实验室有证据表明,候选肥胖信号胰岛素和瘦素降低行为任务的性能,评估食物奖励和需要DA信号。我们推测,中脑DA神经元的细胞体是在腹侧被盖区(VTA)作为胰岛素和瘦素的直接目标。在这个建议中,我们将测试这一假设在大鼠中,通过研究胰岛素或瘦素直接注入腹侧被盖区的行为程序,评估不同方面的食物奖励/动机的影响:一个自由进食摄食任务,条件性位置偏好,自我管理。我们将在这些任务中比较甜食与脂肪食物的奖励,以评估大量营养素的特异性。我们将胰岛素受体反义寡核苷酸直接注入腹侧被盖区,以确定内源性胰岛素信号在调节食物奖励行为中的作用。由于腹侧被盖区DA神经元表达胰岛素和瘦素受体,我们将测量胰岛素和瘦素刺激的PI 3激酶途径作为直接腹侧被盖区激活在细胞水平的指标。将在大鼠中进行可比研究,这些大鼠除喂食普通食物外还喂食规定的高脂肪饮食零食,这是我们最近开发的CNS胰岛素抵抗模型。我们将使用该模型来测试胰岛素和/或瘦素在腹侧被盖区的行为和细胞作用是否被高脂肪饮食摄入所减弱,即,VTA胰岛素或瘦素抵抗模型。这些研究将共同评估肥胖信号对中枢神经系统奖赏回路和功能的潜在调节作用。这些研究的结果将有助于了解改变食物奖励值是否有助于(相对)暴饮暴食的长期目标,这种暴饮暴食与高可口食物的可用性有关,而与热量需求无关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DIANNE FIGLEWICZ LATTEMANN其他文献

DIANNE FIGLEWICZ LATTEMANN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DIANNE FIGLEWICZ LATTEMANN', 18)}}的其他基金

Dietary fatty acids, cell signals, and sucrose intake
膳食脂肪酸、细胞信号和蔗糖摄入量
  • 批准号:
    10046298
  • 财政年份:
    2018
  • 资助金额:
    $ 9.76万
  • 项目类别:
CNS Mechanisms of Acute Hypoglycemia-Associate Autonomic Failure
急性低血糖相关自主神经衰竭的中枢神经系统机制
  • 批准号:
    8258198
  • 财政年份:
    2009
  • 资助金额:
    $ 9.76万
  • 项目类别:
CNS Mechanisms of Acute Hypoglycemia-Associate Autonomic Failure
急性低血糖相关自主神经衰竭的中枢神经系统机制
  • 批准号:
    7782818
  • 财政年份:
    2009
  • 资助金额:
    $ 9.76万
  • 项目类别:
CNS Mechanisms of Acute Hypoglycemia-Associate Autonomic Failure
急性低血糖相关自主神经衰竭的中枢神经系统机制
  • 批准号:
    7686674
  • 财政年份:
    2009
  • 资助金额:
    $ 9.76万
  • 项目类别:
CNS Mechanisms of Acute Hypoglycemia-Associate Autonomic Failure
急性低血糖相关自主神经衰竭的中枢神经系统机制
  • 批准号:
    8195898
  • 财政年份:
    2009
  • 资助金额:
    $ 9.76万
  • 项目类别:
ANTIDEPRESSANT THERAPY AND HYPOGLYCEMIA
抗抑郁治疗和低血糖
  • 批准号:
    6954866
  • 财政年份:
    2005
  • 资助金额:
    $ 9.76万
  • 项目类别:
ANTIDEPRESSANT THERAPY AND HYPOGLYCEMIA
抗抑郁治疗和低血糖
  • 批准号:
    7140214
  • 财政年份:
    2005
  • 资助金额:
    $ 9.76万
  • 项目类别:
CNS Stress Pathways and the Development of Acute HAAF
CNS 应激通路与急性 HAAF 的发展
  • 批准号:
    6645366
  • 财政年份:
    2002
  • 资助金额:
    $ 9.76万
  • 项目类别:
CNS Stress Pathways and the Development of Acute HAAF
CNS 应激通路与急性 HAAF 的发展
  • 批准号:
    6548808
  • 财政年份:
    2002
  • 资助金额:
    $ 9.76万
  • 项目类别:
BEHAVIORAL PHYSIOLOGY OF BODY WEIGHT REGULATION
体重调节的行为生理学
  • 批准号:
    2444021
  • 财政年份:
    1988
  • 资助金额:
    $ 9.76万
  • 项目类别:

相似海外基金

Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
  • 批准号:
    10759950
  • 财政年份:
    2023
  • 资助金额:
    $ 9.76万
  • 项目类别:
Inducing H3F3A exon skipping with antisense oligonucleotides as an approach to treat diffuse intrinsic pontine glioma
用反义寡核苷酸诱导 H3F3A 外显子跳跃作为治疗弥漫性内源性脑桥胶质瘤的方法
  • 批准号:
    10677284
  • 财政年份:
    2023
  • 资助金额:
    $ 9.76万
  • 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
  • 批准号:
    10464020
  • 财政年份:
    2022
  • 资助金额:
    $ 9.76万
  • 项目类别:
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy
使用反义寡核苷酸促进成人海马神经发生作为阿尔茨海默氏病的治疗
  • 批准号:
    10484703
  • 财政年份:
    2022
  • 资助金额:
    $ 9.76万
  • 项目类别:
Strategy for specific delivery of antisense oligonucleotides to T cells
将反义寡核苷酸特异性递送至 T 细胞的策略
  • 批准号:
    10547347
  • 财政年份:
    2022
  • 资助金额:
    $ 9.76万
  • 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10806783
  • 财政年份:
    2022
  • 资助金额:
    $ 9.76万
  • 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10689248
  • 财政年份:
    2022
  • 资助金额:
    $ 9.76万
  • 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10501862
  • 财政年份:
    2022
  • 资助金额:
    $ 9.76万
  • 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
  • 批准号:
    10623180
  • 财政年份:
    2022
  • 资助金额:
    $ 9.76万
  • 项目类别:
Identifying binding partners, biological substrates and antisense oligonucleotides regulating expression of short and long ACE2.
识别调节短和长 ACE2 表达的结合伴侣、生物底物和反义寡核苷酸。
  • 批准号:
    BB/V019848/1
  • 财政年份:
    2021
  • 资助金额:
    $ 9.76万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了